Recruiting studies: Urinary Bladder Diseases Urologic Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Inte
Phase 3 · 1 location(s) · Fujian Medical University Union Hospital · NCT06441110 T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
Phase N/A · 2 location(s) · University Hospital, Basel, Switzerland · NCT07581496 Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
NA · 6 location(s) · Tianjin Medical University Second Hospital · NCT07187635 A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasiv
Phase 3 · 112 location(s) · Janssen Research & Development, LLC · NCT06919965 ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Phase N/A · 57 location(s) · Guardant Health, Inc. · NCT05059444 NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
Phase 2/Phase 3 · 1 location(s) · Peter Black · NCT06537154 Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931 Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
NA · 17 location(s) · Hospices Civils de Lyon · NCT03787056 Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours
Phase 4 · 1 location(s) · University of Roma La Sapienza · NCT05962541 Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Phase 2 · 4 location(s) · Kyoto University Hospital · NCT05879653 Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05204186 Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT06580002 PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bl
Phase 1 · 1 location(s) · University of California, Davis · NCT06173349 Home-Based Transcutaneous Remotely Monitored Posterior Tibial Neuromodulation
NA · 1 location(s) · Ege University · NCT07081412 Percutaneous Nerve Evaluation Trial Time
NA · 1 location(s) · University of Chicago · NCT06226220 Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
NA · 1 location(s) · Changhai Hospital · NCT06889623 Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
NA · 4 location(s) · Yi Zhang · NCT06198517 Vacuum-Assisted Mini-Percutaneous Versus Transurethral Cystolithotripsy in Pediatric Bladder Stones
NA · 1 location(s) · Beni-Suef University · NCT07614880 Improving Overactive Bladder Treatment Access and Adherence
NA · 1 location(s) · Stanford University · NCT06094543 Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infecti
Phase 1 · 2 location(s) · University of Texas Southwestern Medical Center · NCT06907199 A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · 158 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632 Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Phase 1 · 1 location(s) · Monopar Therapeutics · NCT06337084 Intervention of Bladder Cancer by CAR-T
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03185468 Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
Phase 4 · 6 location(s) · Peking University First Hospital · NCT04532606 The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non
Phase N/A · 2 location(s) · Tianjin Medical University Second Hospital · NCT07130578 A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Phase 1 · 4 location(s) · Pilatus Biosciences Inc · NCT07337525 A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · 21 location(s) · Clasp Therapeutics, Inc. · NCT06778863 DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
Phase 1/Phase 2 · 7 location(s) · University College, London · NCT04106115 Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity
Phase 4 · 1 location(s) · Mackay Memorial Hospital · NCT05968885 Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT00499317

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →